ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

ClinicalTrials.gov ID: NCT02201524

Public ClinicalTrials.gov record NCT02201524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 12:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis

Study identification

NCT ID
NCT02201524
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
59 participants

Conditions and interventions

Interventions

  • PF-04965842 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2014
Primary completion
Aug 31, 2015
Completion
Aug 31, 2015
Last update posted
Oct 4, 2016

2014 – 2015

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Total Skin and Beauty Dermatology Center, PC Birmingham Alabama 32505
Northwest Arkansas Clinical Trials Center, PLLC/Hull Dermatology, PA Rogers Arkansas 72758
California Dermatology & Clinical Research Institute Encinitas California 92024
Dermatology Research Associates Los Angeles California 90045
Dermatology Specialists, Inc. Oceanside California 92056
Huntington Medical Foundation/Specialty Office Pasadena California 91105
Clinical Science Institute Santa Monica California 90404
Olympian Clinical Research Clearwater Florida 33756
Westcoast Radiology Services Clearwater Florida 33756
North Florida Dermatology Associates, PA Jacksonville Florida 32204
International Dermatology Research, Inc. Miami Florida 33144
Park Avenue Dermatology, PA Orange Park Florida 32073
Leavitt Medical Associates of Florida d/b/a Ameriderm Research Ormond Beach Florida 32174
Advanced Medical Research, Inc Atlanta Georgia 30342
Columbus Dermatology, P.C. Columbus Georgia 31904
Columbus Regional Research Institute Columbus Georgia 31904
Dundee Dermatology West Dundee Illinois 60118
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
Dawes Fretzin Dermatology Group, LLC Indianapolis Indiana 46256
DS Research Louisville Kentucky 40202
Shondra L Smith, MD Lake Charles Louisiana 70605
Clinical Pharmacology Study Group Worcester Massachusetts 01605
Dartmouth-Hitchcock Medical Center - Section of Dermatology Lebanon New Hampshire 03756
Mount Sinai Medical Center New York New York 10029
Duke University Medical Center - Shipment Only Durham North Carolina 27710
Duke University Medical Center Durham North Carolina 27710
Dermatology Consulting Services High Point North Carolina 27262
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Clinical Partners, LLC Johnston Rhode Island 02919
Health Concepts Rapid City South Dakota 57702
Arlington Research Center, Inc. Arlington Texas 76011
Dermatology Treatment & Research Center, PA Dallas Texas 75230
Center for Clinical Studies Houston Texas 77004
Virginia Clinical Research Norfolk Virginia 23507
Premier Clinical Research Spokane Washington 99202-1480

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02201524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 4, 2016 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02201524 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →